[Treatment of pyknoleptic petit mal epilepsy and juvenile myoclonic epilepsy with dipropyl acetate (Deprakine). A pilot study of therapy-resistant patients during control of plasma concentration]

[Article in Danish]

Clinical Trial

[Article in Danish]

M Schroll et al. Ugeskr Laeger. 1977.

. 1977 May 2;139(18):1073-7.

No abstract available

Similar articles

[The treatment of primary generalized epilepsies with dipropyl acetate (DPA)].
Lagenstein I, Blaschke-Zimmermann E, Iffland E, Sternowsky HJ, Fehr R. Lagenstein I, et al. Fortschr Med. 1977 Apr 7;95(13):892-6. Fortschr Med. 1977. PMID: 403114 German.
[Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study].
Gram L, Wulff K, Rasmussen KE, Flachs H, Würtz-Jørgensen A, Sommerbeck KW, Løhren V. Gram L, et al. Ugeskr Laeger. 1977 May 2;139(18):1064-9. Ugeskr Laeger. 1977. PMID: 324058 Clinical Trial. Danish. No abstract available.
Sodium valproate for the treatment of childhood epilepsies.
Silberstein P. Silberstein P. Med J Aust. 1977 Jan 22;1(4):95, 98-9. doi: 10.5694/j.1326-5377.1977.tb130532.x. Med J Aust. 1977. PMID: 403393
Drug therapy: Valproic acid.
Koch-Weser J, Browne TR. Koch-Weser J, et al. N Engl J Med. 1980 Mar 20;302(12):661-6. doi: 10.1056/NEJM198003203021204. N Engl J Med. 1980. PMID: 6766529 Review. No abstract available.
Use of ethosuximide and valproate in the treatment of epilepsy.
Wallace SJ. Wallace SJ. Neurol Clin. 1986 Aug;4(3):601-16. Neurol Clin. 1986. PMID: 3092003 Review.